Industry News



Industry News
Global Trends
Events Calendar
Web Links

Web Gallery

Advertising  Info



Domestic medical device makers seek hike in basic custom duty

The government needs to increase the basic customs duty on medical devices in the range of 5-15 per cent to promote domestic manufacturing, Association of Indian Medical Device Industry (AiMeD) said today.

The current slab is 0-7.5 per cent, it said. "The government has rightly revised custom duty on Electronics to up to 20 per cent recently to maintain the investment climate, and same is sought for Medical Electronics where import dependency is 90 per cent," AiMeD Forum Coordinator Rajiv Nath told PTI.

He said nominal import duty on critical items is not protectionism but sound 'Make in India' economics.

The industry body urged the government to introspect as to why, even after three years of the 'Make in India' campaign, the medical device manufacturing is still floundering.

On its expectations from the Union Budget (2018-19), AiMeD said the medical devices sector expects, "extension of inverted duty tariff rationalisation to medical electronics & diagnostics". It also urged the government to expedite buy Indian policy drafted by Department of Pharmaceuticals which is pending with Ministry of Health & Family Welfare.

AiMeD also asked the Department of Pharmaceuticals to accelerate trade margin capping proposal in the range of 50- 100 per cent, depending on the cost of the devices.


PolyOne to Begin Thermoplastic Elastomer Production in India

PolyOne Corporation (NYSE: POL) today announced it expects to begin production of thermoplastic elastomers (TPEs) this summer at its existing facility in Pune, India. PolyOne currently produces color and additive concentrates and engineered polymer solutions at the Pune facility. Adding TPE production enables the company to support customers in the country even more quickly and with a broader portfolio of domestically manufactured materials.

“This investment at our facility in Pune answers customers’ desire for a domestic supplier able to offer expertise in color, engineered materials and thermoplastic elastomers,” said Craig Nikrant, president, Specialty Engineered Materials, PolyOne. “We are the only global company to offer all of these domestically produced materials in India. Customers benefit from shorter lead times due to domestic production, and also from our global network of polymer science expertise.”


Inauguration of Clariant's new healthcare packaging plant in Cuddalore, Tamil Nadu

Clariant in India has established its eminence in the specialty chemicals sector, with its presence in the country for more than 50 years. Clariant in India is living the “Make in India” mantra, and has built a manufacturing hub for both exports and domestic markets. It comprises 11 production sites spread across Maharashtra, Gujarat, Madhya Pradesh, Tamil Nadu and Telangana. Clariant in India aims for accelerated growth in the Indian market through the six business units i.e. Masterbatches, Pigments, Additives, Industrial & Consumer Specialties, Catalysts and Functional Minerals.

Adnan Ahmad, Region Head, Clariant in India said, “Clariant is ambitious in India and we look to create a material and profitable specialty chemical business through our new greenfield plant for healthcare packaging. While this plant may not fall in the specialty chemicals category in the traditional sense, but it is certainly a differentiated product offering. In India, Business Line Medical Specialties has grown over the past few years and this facility will give us clear edge against the competition.”

Ketan Premani, India Head of Business Unit - Medical Specialties said, “Our new greenfield healthcare packaging production plant, technology-wise is ‘state-of-the-art’. It is the first and so far the only ISO-8 clean room facility in the group and particularly in emerging markets of the world. The facility will offer Desiccants and link our customers to Clariant's global packaging design capabilities. Pharmaceutical regulatory compliance and consistent quality is the hallmark of our offerings to the customers”

Other News

QCI, AMTZ and AiMeD form Indian Bio-Medical Skill Consortium to certify capacity of Indian biomedical engineers
MTaI pitches for tax breaks to medical device R&D centres to boost investment in innovation based in-house capabilities centres





Back | Back To Top | Previous